Normally, the immune system recognizes and eliminates abnormal cells. However, cancer cells can develop strategies to evade ...
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...
Automated TCR-T production streamlines personalized immunotherapy, reducing patient burden and improving engineered T cell quality.
Dietary restriction reshapes CD8+ T cell metabolism by increasing ketone body–driven acetyl-CoA production, preventing ...
Survival rarely comes easy when pancreatic ductal adenocarcinoma strikes. Most people learn of it only after it has spread, ...
Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...
Ouro Medicines’ BCMAxCD3 T cell engager antibody candidate, gamgertamig gets US FDA orphan drug designation to treat immune thrombocytopenia: South San Francisco Tuesday, Decemb ...
Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...
Injectable scaffold vaccines enhance host immunity by driving cytokine production and strengthening antigen specific cell ...